sorafenib has been researched along with rutin in 2 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (rutin) | Trials (rutin) | Recent Studies (post-2010) (rutin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 4,105 | 244 | 1,778 |
Protein | Taxonomy | sorafenib (IC50) | rutin (IC50) |
---|---|---|---|
Lysine-specific histone demethylase 1A | Homo sapiens (human) | 2.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alsaif, NA; Bakheit, AH; Wani, TA; Zargar, S | 1 |
Hu, J; Huang, L; Lan, H; Lv, Y; Shen, X; Zhang, G; Zhou, M; Zhu, Y | 1 |
2 other study(ies) available for sorafenib and rutin
Article | Year |
---|---|
Multi-spectroscopic investigation, molecular docking and molecular dynamic simulation of competitive interactions between flavonoids (quercetin and rutin) and sorafenib for binding to human serum albumin.
Topics: Binding Sites; Circular Dichroism; Humans; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Quercetin; Rutin; Serum Albumin, Human; Sorafenib; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermodynamics | 2020 |
Rutin attenuates Sorafenib-induced Chemoresistance and Autophagy in Hepatocellular Carcinoma by regulating BANCR/miRNA-590-5P/OLR1 Axis.
Topics: Animals; Antineoplastic Agents; Autophagy; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA, Long Noncoding; Rutin; Scavenger Receptors, Class E; Sorafenib; Xenograft Model Antitumor Assays | 2021 |